Your browser doesn't support javascript.
loading
Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia.
Burmeister, Thomas; Ströh, Aeint-Steffen; Kehden, Britta; Trautmann, Heiko; Meyer, Claus; Marschalek, Rolf; Larghero, Patrizia; Schwartz, Stefan; Steffen, Björn; Spriewald, Bernd; Heinicke, Thomas; Jäkel, Nadja; Westermann, Jörg; Nachtkamp, Kathrin; Viardot, Andreas; Topp, Max S; Neumann, Martin; Baldus, Claudia D; Gökbuget, Nicola; Brüggemann, Monika.
Afiliação
  • Burmeister T; Department of Hematology, Oncology and Tumor Immunology, CVK, Charité-Universitätsmedizin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. thomas.burmeister@charite.de.
  • Ströh AS; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.
  • Kehden B; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Trautmann H; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.
  • Meyer C; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Marschalek R; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.
  • Larghero P; Department of Medicine II, Hematology and Oncology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Schwartz S; Diagnostic Center of Acute Leukemia (DCAL), Institute of Pharmaceutical Biology, Goethe University, Frankfurt, Germany.
  • Steffen B; Diagnostic Center of Acute Leukemia (DCAL), Institute of Pharmaceutical Biology, Goethe University, Frankfurt, Germany.
  • Spriewald B; Diagnostic Center of Acute Leukemia (DCAL), Institute of Pharmaceutical Biology, Goethe University, Frankfurt, Germany.
  • Heinicke T; Department of Hematology, Oncology and Tumor Immunology, CBF, Charité Universitätsmedizin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Jäkel N; Department of Medicine II, Goethe University, University Hospital, Frankfurt, Germany.
  • Westermann J; University Hospital Erlangen, Department of Internal Medicine 5, Hematology and Oncology, Erlangen, Germany.
  • Nachtkamp K; Department of Hematology and Oncology, Otto-von-Guericke University Hospital, Magdeburg, Germany.
  • Viardot A; Department of Hematology, Oncology, University Hospital, Halle/Saale, Germany.
  • Topp MS; Department of Hematology, Oncology and Tumor Immunology, CVK, Charité-Universitätsmedizin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Neumann M; Department of Hematology, Oncology, University Hospital of Düsseldorf, Düsseldorf, Germany.
  • Baldus CD; Department of Hematology, Oncology, University Hospital Ulm, Ulm, Germany.
  • Gökbuget N; Department of Hematology, Oncology, University Hospital Würzburg, Würzburg, Germany.
  • Brüggemann M; University Cancer Center Schleswig-Holstein (UCCSH), University Hospital Schleswig-Holstein, Kiel, Germany.
Leukemia ; 38(7): 1600-1603, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38519799

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rearranjo Gênico / Histona-Lisina N-Metiltransferase / Neoplasia Residual / Proteína de Leucina Linfoide-Mieloide / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rearranjo Gênico / Histona-Lisina N-Metiltransferase / Neoplasia Residual / Proteína de Leucina Linfoide-Mieloide / Leucemia-Linfoma Linfoblástico de Células Precursoras Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article